Koninklijke DSM Profile

USD 0.14  0.52%

Koninklijke DSM Summary

Koninklijke DSM N V (RDSMY) is traded on OTC Market in USA. It is located in Het Overloon 1 and employs 20,870 people. The company currently falls under 'Large-Cap' category with current market capitalization of 18.07 B. Koninklijke DSM N V has 174.9 M outstanding shares. ROYAL D S M NV AD has accumulated about 2.36 B in cash with 1.28 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.37.
Check Koninklijke DSM Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 25.88HorizonTargetOdds Above 25.88
?%30 days 25.88 ?%
Based on normal probability distribution, the odds of Koninklijke DSM to move above current price in 30 days from now is about 0.0% (This Koninklijke DSM N V probability density function shows the probability of Koninklijke DSM Stock to fall within a particular range of prices over 30 days) .

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Parametric Portfolio Associates LlcCommon Shares557.1 K13.8 M
World Asset Management IncCommon Shares28.9 K716 K
View Koninklijke DSM Diagnostics

Key Fundamentals

Koninklijke DSM Against Markets

Current Ratings

Koninklijke DSM 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Koninklijke DSM N V are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Koninklijke DSM N.V., a science-based company, engages in health, nutrition, and materials businesses worldwide. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands. Koninklijke DSM is traded on OTC Market in USA. more
NameKoninklijke DSM N V
ChairmanRobert RoutsView All
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressHet Overloon 1
ExchangeOTC Market
SectorBasic Materials
Contact Number31 45 578 2864
CurrencyUSD - US Dollar


Koninklijke DSM Analyst Recommendations
Target PriceAdvice# of Analysts
18.57Strong Buy1Odds
Koninklijke DSM N V current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Koninklijke DSM Analyst Advice  


Koninklijke DSM Earnings Estimates
Koninklijke DSM N V normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


Koninklijke DSM Corporate Management
Eileen Kennedy Member of the Supervisory Board
Frits Paasschen Independent Member of the Supervisory Board
John Ramsay Independent Member of the Supervisory Board
Stefan Doboczky Member of the Managing Board, MBA
Stephan Tanda Member of the Managing Board
Additionally take a look at Your Equity Center. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.